Filter
1427
Text search:
dosage
Featured
198
397
Language
Document type
733
327
164
80
55
22
18
10
8
4
3
1
1
Countries
106
43
43
41
38
31
29
26
26
25
20
18
18
17
17
16
16
15
15
15
13
12
12
12
12
11
10
10
9
8
7
7
7
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
598
203
95
69
42
23
19
1
Toolboxes
126
109
101
91
73
63
39
36
30
30
23
14
13
13
13
9
9
8
7
7
6
5
4
2
1. Provide treatment for mental disorders in primary care
2. Ensure wider accessibility to essential psychotropic drugs
3. Provide care in the community
4. Educate the public
5. Involve communities, families and consumers
6. Establish national policies, programmes and legislation on mental heal
...
Q7: What is the effectiveness, safety and role of pharmacological and non-pharmacological interventions, within non- specialist health care for children with a diagnosis of Attention-deficit hyperactivity disorder (ADHD)?
Cognitive deficits in schizophrenia can massively impact functionality and quality of life, furthering the importance of cognitive training. Despite the development of the field in Europe and in the United States, no programmes have been developed and tested in developing countries. Different cultur
...
Developmental disorders
Chapter C.5
Depress Anxiety. 2018 March ; 35(3): 195–208. doi:10.1002/da.22711.
Dialogues Clin Neurosci. 2017 Jun; 19(2): 93–107.
The purpose of the Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care is to provide professionals with practical recommendations based on scientific evidence to assist in the detection and effective treatment of these disorders
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
PLoS Med. 2009 Oct;6(10):e1000159. doi: 10.1371/journal.pmed.1000159. Epub 2009 Oct 6.
NICE guideline
Published: 23 May 2017
Best practice portal: standards and guidelines
recommended
The Best practice portal is a resource for professionals, policymakers and researchers in the drugs field. We provide information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the European context. The evidence is compiled following an explicit metho
...
This casebook collects 64 case studies, each of which raises an important and difficult ethical issue connected with planning, reviewing, or conducting health-related research. The book’s purpose is to contribute to thoughtful analysis of these issues by researchers and members of research ethics
...
The seven essential features of practice for scaling up are described with great clarity. They are practical and universal, and encourage local innovation. They include policy, funding and local management structure, as well as working with all possible partners and developing local context adaptati
...
The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool for health care providers as well as governments, pol
...
Accessed June 17,2019
